Finance

Lists
Why is ALT down 7,52%?
Dive Deeper
ALT:NASDAQ
Altimmune Inc
1,42 $
-7,52%
(-0,12) 1D
18 նոյ, 13:18:04 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALT...
Open
1,53 $
High
1,53 $
Low
1,40 $
Mkt. cap
275,34 մլն
Avg. vol.
3,91 մլն
Volume
2,46 մլն
52-wk high
6,44 $
52-wk low
1,40 $
EPS
-0,72 $
Beta
0,16
Shares outstanding
194,59 մլն
No. of employees
57
Open
1,53 $
High
1,53 $
Low
1,40 $
Mkt. cap
275,34 մլն
Avg. vol.
3,91 մլն
Volume
2,46 մլն
52-wk high
6,44 $
52-wk low
1,40 $
EPS
-0,72 $
Beta
0,16
Shares outstanding
194,59 մլն
No. of employees
57
News stories
From web sources and news partners
About Altimmune Inc
CEOJerry Durso
Employees57
Founded1997
HeadquartersGaithersburg, Մերիլենդ, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Analyst ratings
Based on 4 analysts giving stock ratings to ALT in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ALT in the last 3 months.
Highest
Current 1,42 $
20,00 $ (+1 313,43%)
Average
17,00 $ (+1 101,41%)
Lowest
11,00 $ (+677,39%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eliana Merle
Barclays
Buy
Reiterated
20,00 $
+1 313,4%
11/17/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
20,00 $
+1 313,4%
11/17/2026
William Wood
B. Riley Securities
Buy
Maintained
11,00 $
+677,4%
11/13/2026
Liisa Bayko
Evercore ISI
Buy
Maintained
17,00 $
+1 101,4%
09/24/2026
Michael DiFiore
Evercore ISI
Buy
Maintained
17,00 $
+1 101,4%
09/24/2026
Unknown Analyst
Jefferies
Buy
Maintained
28,00 $
+1 878,8%
08/13/2026
Andy Hsieh
William Blair
Hold
Reiterated
-
-
08/12/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
-
-
07/29/2026
Thomas Smith
Leerink Partners
Buy
Maintained
10,00 $
+606,7%
07/28/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
11,00 $
+677,4%
05/14/2026
Corinne Johnson
Goldman Sachs
Hold
Upgraded
2,50 $
+76,7%
04/24/2026
Boris Peaker
JonesTrading
Buy
Initiated
7,00 $
+394,7%
02/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
26,00 հզր
-
-
-
Cost of goods sold
18,41 մլն
15,48 մլն
17,86 մլն
27,02 մլն
Cost of revenue
18,41 մլն
15,48 մլն
17,86 մլն
27,02 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,51 մլն
8,05 մլն
7,57 մլն
8,69 մլն
Operating expense
10,51 մլն
8,05 մլն
7,57 մլն
8,69 մլն
Total operating expenses
28,92 մլն
23,54 մլն
25,43 մլն
35,70 մլն
Operating income
-28,89 մլն
-23,54 մլն
-25,43 մլն
-35,70 մլն
Other non operating income
-27,00 հզր
-152,00 հզր
-25,00 հզր
399,00 հզր
EBT including unusual items
-27,36 մլն
-22,56 մլն
-22,82 մլն
-31,61 մլն
EBT excluding unusual items
-27,36 մլն
-21,85 մլն
-22,02 մլն
-31,61 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-27,36 մլն
-22,56 մլն
-22,82 մլն
-31,61 մլն
Net profit margin
-105 223,08%
-
-
-
Earnings per share
-0,27
-0,18
-0,12
-0,15
Interest and investment income
2,44 մլն
2,90 մլն
4,53 մլն
4,82 մլն
Interest expense
-876,00 հզր
-1,07 մլն
-1,10 մլն
-1,12 մլն
Net interest expenses
1,56 մլն
1,83 մլն
3,43 մլն
3,70 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-28,87 մլն
-23,51 մլն
-25,41 մլն
-35,69 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps